Viking's maintenance data, and two cheaper frontier models in one day
Viking Therapeutics rose 35.7% after its GLP-1/GIP drug VK2735 held up to 97% of patients' weight loss on every-other-week dosing and up to 90% on monthly dosing, against 61% for placebo. OpenAI and Anthropic both released cheaper models the same day: GPT-6 Sol and Luna at roughly half their predecessors' API prices, and Claude Opus 5.5, which Anthropic says matches Fable 5.1 on most work at 40% less to run than Opus 5. Trump told the UN a deal with Iran comes after the midterms or he'll 'annihilate' the country, and the S&P finished flat.
- S&P 500
- 0.00%
- Nasdaq 100
- +0.82%
- VIX
- 14.21−4.4%
- Viking
- +35.7%
- 2-year
- 4.71%−5bp
Viking showed the weight stays off on fewer shots
VKTX +35.7%In a 180-patient study, VK2735 took off 16% to 19% of body weight over 21 weeks of weekly dosing, against roughly nothing on placebo. Then patients were switched to less frequent shots for 12 weeks. Every-other-week dosing kept up to 97% of the weight off, monthly dosing up to 90%, and switching to placebo kept 61%. A cohort left on weekly dosing reached about 22% at week 33 with no plateau, and stomach side effects during maintenance were no worse than placebo. Fewer shots is what makes these drugs cheaper to stay on, which is why maintenance data matters to the class as much as the headline weight loss. Viking closed up 35.67% at $40.85. Lilly rose 0.45% and Novo fell 1.01%, so the move stayed with Viking.
OpenAI and Anthropic both cut the price of frontier work
GPT-6 Sol $2/$10 · Opus 5.5 $4/$20OpenAI released GPT-6 Sol at $2 per million input tokens and $10 per million output, down from $4 and $20 for the 5.6 version, and GPT-6 Luna at $0.10 and $0.50, from $0.20 and $1.20. It says Sol makes about half as many factual mistakes as its predecessor. Both sit below GPT-6 Astra, the flagship released earlier this month. Anthropic released Claude Opus 5.5, which it says performs at the level of Claude Fable 5.1 on most work and costs 40% less to run than Opus 5. List prices fell to $4 and $20 from $5 and $25, and output is 30% faster. Both companies are private, and nothing public moved on either announcement that can be pinned to it.
Trump told the UN a deal comes after the midterms, or else
WTI −1.9%Trump told the General Assembly he expects a deal with Iran "right after the election," and that the alternative is to "annihilate" the Islamic Republic. Afterward he said Jared Kushner and Steve Witkoff had a roughly three-hour "very good meeting" with the Iranian delegation on the sidelines. WTI settled near $90.6, down 1.9%, extending yesterday's drop.
A flat S&P, and the CPU trade kept going
ARM +3.2% · AMD +1.3%The S&P finished unchanged to two decimal places, the Nasdaq 100 up 0.82% and the Dow down 0.36%, with the VIX down 4.4% to 14.21. The 2-year fell 5bp to 4.71% and the rest of the curve didn't move. Yesterday's CPU repricing held for a second day: Arm up 3.19%, AMD up 1.34% to another record close.
Sources
- Viking Therapeutics, VK2735 maintenance study results(opens in a new tab)
- OpenAI, Introducing GPT-6 Sol and Luna(opens in a new tab)
- The Next Web on GPT-6 Sol and Luna pricing(opens in a new tab)
- Anthropic, Introducing Claude Opus 5.5(opens in a new tab)
- CBS News on Trump's UN address(opens in a new tab)
- Treasury daily par yield curve(opens in a new tab)